Breast Cancer
News
20-year follow-up supports adjuvant radiotherapy for DCIS
Key clinical point: 20-year follow-up data from the SweDCIS trial show that adjuvant radiotherapy continues to protect “modestly” against invasive...
News
Genetic screen not worth cost for node-negative breast cancer patients
Key clinical point: A 70-gene signature screen for chemotherapy guidance for node-negative breast cancer patients did not lead to better outcomes...
Video
VIDEO: Women with node-positive breast cancer benefit from dose-dense chemo
News
Dose-dense chemo aids high-risk breast cancer patients
Key clinical point: A dose-dense chemotherapy regimen surpassed conventional dosing in high-risk breast-cancer patients. Major finding: A dose-...
News
CLEOPATRA sets new standard treatment paradigm for metastatic breast cancer
Key clinical point: Pertuzumab, trastuzumab, and docetaxel chemotherapy is the new standard for first-line metastatic HER2-positive breast cancer...
Conference Coverage
Biomarker predicts bone loss in premenopausal breast cancer patients
Key clinical point: A premenopausal breast cancer patient’s FSH level upon completion of adjuvant chemotherapy identifies whether she ought to be...
Podcasts
AUDIO: Hope Rugo reviews pivotal breast cancer trials at ESMO
Conference Coverage
VIDEO: CLEOPATRA combo extends survival in HER2-positive metastatic breast cancer
Key clinical point: CLEOPATRA establishes pertuzumab and trastuzumab plus chemotherapy as the standard of care in metastatic HER2-positive breast...
News
Radiation therapy for early breast cancer did not increase lymphedema risk
Key clinical point:The rate of lymphedema did not differ between breast cancer patients with pathologically negative sentinel nodes who did and...